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tutively expressed in cognate cell types, whereas iNOS expression is broadly induced in cells by proinflammatory cytokines, in pathophysiological settings that include atherosclerotic lesions (7) . Each NOS isoform is expressed in atherosclerotic vascular lesions (54) , and isoform-specific NOS gene deletion in the apolipoprotein E (ApoE)-null genetic model of atherosclerosis has demonstrated opposing consequences for disease progression; whereas expression of eNOS and nNOS is disease limiting (19, 23, 32) , iNOS expression is disease promoting (13, 26) . The basis for the opposing roles of NOS isoforms in atherogenesis is incompletely understood, but differences in NO generation rates, cell source, and secondary reaction products are likely to be the major determinants. A further level of complexity arises from the likelihood that each of these putative determinants will vary in a tissue-specific manner during the various stages of atherogenesis.
All NOS isoforms have identical cofactor requirements [heme, flavin adenine dinucleotide, flavin mononucleotide, tetrahydrobiopterin (BH 4 ), and calmodulin] (47) . The reaction mechanism requires electron flow from NADPH for activation of heme-bound O 2 in two successive monooxygenation reactions (46) that each requires BH 4 (43, 45) . Importantly, O 2 consumption must be tightly coupled to electron transfer steps during the NOS catalytic cycle to limit uncoupled O 2 reduction and release as superoxide anion radical (O 2
•Ϫ
). eNOS (49, 53, 55) , nNOS (18, 40) , and iNOS (56) all have the capacity to release O 2 •Ϫ . With deficiency of BH 4 , NOS uncoupling can predominate, manifested by O 2 •Ϫ production in lieu of NO (46) . Given the near-diffusion limited reaction of NO and O 2 •Ϫ to produce peroxynitrite (ONOO Ϫ ), formation of ONOO Ϫ can outcompete the ability of superoxide dismutase to consume O 2 •Ϫ (2, 20) . Importantly, ONOO Ϫ has been shown to efficiently oxidize BH 4 to 7,8-dihydrobipterin (BH 2 ) in vitro and in vivo (24, 27) . Oxidation of BH 4 has been demonstrated to occur in blood vessels, presumably mediated by ONOO Ϫ , under conditions associated with chronic inflammation (1) , and the resulting BH 4 deficiency is implicated as a molecular basis for eNOS uncoupling (28, 49) .
A hallmark reaction of ONOO Ϫ production is nitration of tyrosine residues, leading to 3-nitrotyrosine (3-NT) accumulation in proteins (3) . An alternative pathway that leads to Tyr nitration involves nitrite metabolism by a peroxidase enzyme in the presence of hydrogen peroxide (36, 39) . In human atherosclerotic blood vessels, increased production of vascular O 2 •Ϫ (35, 37) and expression of iNOS (7, 54) have been observed in association with elevated levels of protein 3-NT (30, 44, 48) . Formation of ONOO Ϫ would necessarily abbreviate the bioactive lifetime of NO, dampening the vasoprotective actions afforded by NO. Whereas multiple biochemical sources of O 2 •Ϫ may contribute to NO scavenging in the early stages of chronic vasoinflammatory conditions [perhaps most importantly, activation of NADPH oxidase (15) ], subsequent oxidation of BH 4 can cause uncoupled eNOS to become a sustained source of O 2 •Ϫ (28, 49) . Consequent production of BH 4 -oxidizing species like ONOO Ϫ can significantly promote further ONOO Ϫ formation, via uncoupling of NOSs (56) , and can result in progressive vascular dysfunctions during atherogenesis.
To explore molecular mechanisms in atherogenesis, the ApoE-deficient (ApoE
) mouse has provided a useful genetic model that faithfully represents several aspects of the human condition (57) . Notably, the ApoE amphipathic protein plays a pivotal role in lipoprotein trafficking by stabilizing and solubilizing lipoprotein particles. ApoE, a constituent of chylomicrons, very low-density lipoprotein, intermediate-density lipoprotein, and high-density lipoprotein, acts as a ligand for the receptor-mediated clearance of these particles (33) . Normotensive ApoE Ϫ/Ϫ mice exhibit plasma cholesterol levels that are four to five times greater than ApoE ϩ/ϩ mice and spontaneously develop atherosclerotic lesions even when fed a low-cholesterol diet (57) . When fed a high-fat Western diet, the development of atherosclerotic lesions in ApoE Ϫ/Ϫ mice is exacerbated (5) in association with accelerated endothelial dysfunction (21) and increased formation of proatherogenic reactive nitrogen intermediates (e.g., OONO Ϫ ) (30) . To ascertain the selective contribution of iNOS-derived NO to atherogenesis, an ApoE Ϫ/Ϫ mouse strain was engineered to also be nullizygous for iNOS (13, 23, 26) . Such double-null mice were found to be normotensive and develop atherosclerotic lesions that are indistinguishable in size from those of ApoE Ϫ/Ϫ -iNOS ϩ/ϩ mice when fed a normal chow diet (23) . This finding led to the initial view that iNOS-derived species do not contribute to the progression of atherogenesis in ApoE Ϫ/Ϫ mice. However, when ApoE Ϫ/Ϫ mice were instead fed a Western diet that accelerated lesion development, iNOS gene deletion was found to curtail lesion formation (13, 26) . Thus iNOS-derived NO perpetuates diet-accelerated atherosclerotic lesion formation in ApoE Ϫ/Ϫ mice. Since lesion development is associated with increased nitrative stress, we questioned the extent to which iNOS-derived NO specifically contributes to the genesis of reactive proatherogenic species. To test this, we assessed the contribution of iNOS to ONOO Ϫ formation by quantifying protein 3-NT accumulation and BH 4 oxidation in organs of Western diet-fed ApoE Ϫ/Ϫ mice.
MATERIALS AND METHODS

Animals.
The animal protocol used in these studies was reviewed and approved by the Weill Medical College of Cornell University Care and Use Committee. ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice were generated as described previously (23) . Mice used in these studies were derived from at least six generations of backcross breeding to C57BL/6J mice (23) . ApoE Ϫ/Ϫ -iNOS Ϫ/ϩ heterozygote mice were bred to generate pups that were then genotyped for the iNOS allele by Southern analysis. Primers that are complimentary to portions of exon 11, exon 12, and neomycin (Neo) were used: AGA GTC CTT CAT GAA GCA  CAT GCA (exon 11), TCA GCT TCT CAT TCT GCC AGA TGT  (exon 12) , and CAA TCC ATC TTG TTC AAT GGC CGA (Neo). The primers were mixed one part Neo, two parts exon 11, and one part exon 12. Wild-type mice contain both exons 11 and 12 and give rise to a larger band (ϳ500 base pairs), whereas iNOS Ϫ/Ϫ mice contain exon 11 and Neo and give rise to a smaller band (ϳ340 base pairs). iNOS ϩ/Ϫ mice give rise to both bands. Study design. ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ males and females were designated as the experimental group, and ApoE Ϫ/Ϫ -iNOS ϩ/ϩ served as controls. ApoE Ϫ/Ϫ -iNOS Ϫ/ϩ pups were used as breeding mice. At 3 wk, all mice were weaned. Some mice were euthanized at 3 wk, whereas others were placed either on a Western diet comprising 21.2% (g/100 g) fat, 0.2% cholesterol, and 0% cholate (Harlan Teklad) or on a regular chow diet comprising 23.6% protein, 11.9% fat, and 64.5% carbohydrates (PicoLab Rodent Diet 20, LabDiet). After 24 wk on these diets, mice were euthanized by cervical dislocation, and tissues were harvested for indicated biochemical analyses. Both male and female mice were included in this study, and no attempt was made to assess possible sex differences in protein 3-NT accumulation and BH 4 oxidation levels. The weights of the Western diet-fed ApoE Ϫ/Ϫ -iNOS ϩ/ϩ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice before euthanasia were not significantly different (30.0 Ϯ 0.3 and 29.2 Ϯ 0.7 g, respectively) (11) .
Quantification of protein incorporated 3-NT. Tissues (hearts, lungs, livers, kidneys, brains, and aortae) were rinsed of blood using ice-cold phosphate-buffered saline solution (pH 7.2-7.4), minced with scissors, and then homogenized in 1-5 ml/g wet wt of tissue in buffer containing (in mM) 50 Tris, 150 NaCl, 0.1 EDTA, and 20 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) (pH 7.4). For aortae, it was necessary to pool tissues from two to three mice for these measurements. The tissue homogenates (100 -500 l) were ultracentrifuged (100,000 g) for 30 min, and the supernatants were subjected to protein assay and complete proteolytic digestion with proteinase K (10 U/mg protein; 8 h at 55°C). Each digested sample was extracted with three volumes of ice-cold acetonitrile, vortexed, incubated on ice (5 min), and centrifuged (12,000 g; 15 min at 4°C). The supernatants were dried by vacuum centrifugation (ϳ4 h at room temperature; SpeedVac concentrator, Savant Model SV100) and reconstituted in vacuum-filtered (0.2-m nylon membrane) and degassed HPLC mobile-phase buffer [containing 90 mM sodium acetate, 35 mM citric acid, 130 M EDTA, and 460 M sodium octane sulfonate (pH 4.35)], prepared in 18-M⍀ resistance water (ϳ2,000 g/injection volume). The samples were centrifuge filtered (molecular mass cutoff ϭ 10 kDa; Microcon Ultracel YM-10) to remove high molecular mass species before analysis for proteinincorporated 3-NT.
An isocratic HPLC system with multichannel electrochemical CoulArray (ESA) detection was used to resolve 3-NT from background species using a 100-mm C18 column (Microsorb-MV, Varian) running an isocratic mobile phase (90 mM sodium acetate, 35 mM citric acid, 130 M EDTA, and 460 M sodium octane sulfonate, pH 4.35) (9, 34). The flow was 0.75 ml/min at 30°C. The optimum potential for detection of 3-NT was found to be ϩ800 mV. To assess the selectivity of the system for 3-NT, two other electrodes were set to bracket the optimal detection potential: ϩ700 and ϩ900 mV, respectively. Confirmation of 3-NT elution was further established by an addition of 10 mM sodium hydrosulfite to putative 3-NT-containing samples. This treatment chemically reduces 3-NT to 3-aminotyrosine, silencing the otherwise observed 3-NT electrochemical signal at ϩ800 mV.
Quantification of BH2 and BH4 in tissue extracts. Tissues (hearts, lungs, livers, kidneys, brains, and aortae) were rinsed of blood using ice-cold phosphate-buffered saline solution (pH 7.2-7.4), minced with scissors, and then homogenized in 1-5 ml/g wet wt of tissue in buffer containing (in mM) 50 Tris, 150 NaCl, 0.1 EDTA, and 20 mM CHAPS (pH 7.4). For aortae, we pooled tissues from three mice for each measurement. Ice-cold protein precipitation buffer (300 l; 0.1 M phosphoric acid and 0.23 M TCA) was added to the tissue homogenate (100 l aliquot), followed by immediate centrifugation (2 min at 12,000 g; 4°C). A portion of the resulting supernatant (100 -150 l) was placed in an HPLC autosampler vial, mixed with dithioerythritol (6 mM final concentration), and analyzed for biopterins by electrochemical and fluorometric detection.
Samples were injected onto an HPLC system configured with sequential multichannel electrochemical CoulArray (ESA) and fluorescence detection. Biopterins were resolved isocratically with a 100-mm C18 column (Microsorb-MV, Varian, CA) running mobile phase (50 mM sodium acetate, 5 mM citric acid, 48 M EDTA, and 0.3 mM dithioerythritol, pH 5.2) at a flow rate of 0.75 ml/min and at room temperature or 30°C. The optimum potential for detection of BH 4 was determined to be ϩ125 mV. Two additional electrodes were set sequentially at Ϫ350 and ϩ600 mV to restore initial BH 4 levels (via reduction) and then fully oxidize biopterins within the sample, respectively, allowing for confirmation of BH 4 presence and detection of all biopterins based on fluorescence, irrespective of redox state. Quantifications of BH 4, BH2, and biopterin were done by comparison with external standards after normalizing for sample protein content.
Western blot analysis of tissue homogenates. Tissues were homogenized in a minimum volume (500 l) of lysis buffer [containing 50 mM Tris ⅐ HCl (pH 8), 10 mM EDTA, 1% Tween 20, 10 g/ml aprotinin, 10 g/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride], sonicated, and centrifuged (13,000 rpm), as described previously (12) . Proteins in the tissue supernatants (30 -40 g) were separated by SDS/PAGE (7.5% polyacrylamide gel). Proteins from the gel were transferred to Immobilon-FL polyvinylidene difluoride membranes (Millipore), which were rinsed and allowed to dry (2 h or overnight) before probing with specific antibodies. Membranes were blocked (5%; 1 h) and then incubated overnight with either a polyclonal rabbit iNOS (sc-650; Santa Cruz) in milk (1%) or monoclonal mouse eNOS (No. 610296; BD Transduction) or nNOS (No. 610308; BD Transduction) antibodies in BSA (1%). After primary incubation, membranes were washed and probed with goat-anti mouse secondary antibody (No. 170-6516; Bio-Rad) in milk (5%; 1 h). When using eNOS and nNOS antibodies, membranes were blocked (in 5% milk; 1 h), again following incubation with the primary antibody as directed by the manufacturer's instructions. Membranes were then washed and probed with a secondary antibody [iNOS: anti-rabbit secondary antibody, sc-2004 (Santa Cruz), in 1% milk for 1 h; eNOS and nNOS: goat-anti mouse secondary antibody, No. 170-6516 (Bio-Rad) 5% in milk for 1 h]. All blots were also probed for actin using a polyclonal goat actin antibody (No. sc-1615; Santa Cruz) in milk (1%; 90 min) and an anti-goat secondary antibody (No. sc-2922; Santa Cruz) in milk (1%; 1 h). Bands were visualized by enhanced chemiluminescence (RPN2132; ECL Plus Western Blotting Detection Kit, GE Healthcare) on film (Kodak BioMax MR film) and scanner (Typhoon Trioϩ Variable Mode; GE Healthcare). Some membranes were stripped and reprobed. Toward this end, membranes were incubated with a stripping solution [containing 62.5 mM Tris ⅐ HCl (pH 6.8), 2% SDS, and 0.1 M 2-mecaptoethanol] in a shaking hot water bath (50°C for 30 min).
Measurement of serum lipid profiles. Blood was removed from euthanized mice from the right ventricle and atrium following a surgical opening of the thoracic cavity. The blood was placed on ice (10 min), centrifuged (3,300 g for 5 min), and stored at 4°C. Glucose was measured using a FreeStyle Blood Glucose Meter (Therasense, Alameda, CA). Cholesterol, LDL, and triglycerides were measured using Cholesterol E, L-Type LDL-C and L-Type TG H assay kits (Wako Chemicals USA, Richmond, VA), respectively. The kits were used according to protocols supplied by the manufacturer.
Statistical analyses. Data are presented as means Ϯ SE with significant differences determined by a two-tailed nonparametric Mann-Whitney t-Test. P Ͻ 0.05 was defined as being statistically significant.
RESULTS
Western diet-evoked increases in protein 3-NT accumulation and BH 4 oxidation in ApoE
Ϫ/Ϫ mouse tissues. Hearts, lungs, livers, kidneys, and brains were harvested from 3-and 27-wkold ApoE Ϫ/Ϫ mice for comparison of protein (3-NT) and BH 4 /BH 2 levels. The elder mice were fed a Western (atherogenic) diet during the 24 wk immediately before being euthanized (see MATERIALS AND METHODS for details).
As shown in Fig. 1A , protein 3-NT levels were relatively low in all examined tissues of 3-wk-old ApoE Ϫ/Ϫ mice (i.e., 5-20 pmol/mg), except in brain, where levels were somewhat greater (Ϸ50 pmol/mg protein), and in heart, where levels were below the limit of detection (Ͻ1 pmol/mg protein). Following 24 wk on a Western diet, 3-NT levels increased significantly in kidney, lung, and heart to a level that was 10-fold to Ͼ280-fold over prediet levels measured in 3-wk-old ApoE Ϫ/Ϫ mice. A 24-wk Western diet also failed to elicit a significant increase in protein 3-NT levels in the brain, beyond the relatively high prediet brain levels found in 3-wk-old mice.
The total biopterin content (sum of BH 4 and BH 2 ) in organs of 3-wk-old ApoE Ϫ/Ϫ mice ranged from a low of 2 pmol/mg protein in heart to a high of 25 pmol/mg protein in liver; intermediary levels were found in lung, brain, and kidney, in that order (see Fig. 1, B and C) . Notably, total biopterin was found exclusively in its fully reduced form, BH 4 , in hearts, lungs, kidneys, and brains of 3-wk-old mice (Fig. 1B) , i.e., BH 2 was essentially undetectable (Fig. 1C) . In liver, a minor but significant fraction of total biopterin was found in 3-wk-old mice as BH 2 (Ϸ13%) (Fig. 1C) , with the remainder being BH 4 (Fig. 1B) . We were unable to detect the further-oxidized species, biopterin, in any tissue examined. The relatively high liver levels of BH 4 and BH 2 found are in accord with a hepatic role of BH 4 as a releasable redox-active cofactor for support of aromatic amino acid hydroxylases; this is in contrast to the predominant function of lower BH 4 levels in NOS-rich tissues as a tightly bound cofactor. Following 24 wk on a Western diet, the total biopterin content of some organs increased significantly, up to twofold (in heart, lung, and liver), whereas in others it did not significantly change (kidney and brain); nonetheless, in all organs, a significant accumulation of BH 2 was observed (Fig. 1C) . The extent of BH 2 accumulation ranged from 34 -50% of the total biopterin in the organs studied. Notably, the atherogenic diet-evoked accumulation of BH 2 on a percent basis was low in brain, where protein 3-NT accumulation was also among the least.
iNOS gene deletion attenuates the accumulation of protein 3-NT and BH 2 in tissues of Western diet-fed ApoE
Ϫ/Ϫ mice. Experiments were performed to assess the extent to which iNOS expression is required for Western diet-evoked protein 3-NT accumulation and BH 4 oxidation in ApoE Ϫ/Ϫ mouse organs. ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice were used for this purpose. Similar experiments were conducted to investigate the effects of feeding these mice a regular chow diet for 24 wk. Figure 2 shows the influence of iNOS gene expression on protein 3-NT accumulation in hearts, lungs, livers, kidneys, and brains of ApoE Ϫ/Ϫ mice fed a regular chow diet (Fig. 2 , left) and a Western diet (Fig. 2, right) for 24 wk. With respect to mice fed a regular chow diet, there were no differences in 3-NT levels measured in organs from ApoE Ϫ/Ϫ mice with and without the presence of iNOS, apart from the heart (5.80 Ϯ 2.9 pmol/mg protein in iNOS Ϫ/Ϫ mice vs. 39.3 Ϯ 12.2 pmol/mg protein in iNOS ϩ/ϩ mice). In mice fed a Western diet, the results show that the majority of diet-evoked 3-NT accumulation in most organs is dependent on iNOS gene expression. Indeed, protein 3-NT accumulation was suppressed by iNOS gene deletion in heart by 76% (70. ϩ/ϩ mice), suggesting a contribution of other NOS isoforms to protein nitration in these organs. Even in heart, where a 76% decrease in protein 3-NT accumulation was observed in iNOS Ϫ/Ϫ mice, the residual 24% of 3-NT accumulation suggests that another NOS isoform importantly contributes to atherogenesis-associated protein nitration. Figure 3 shows the influence of iNOS gene expression on the biopterin content (BH 4 and BH 2 , individually) of hearts, lungs, livers, kidneys, and brains of ApoE Ϫ/Ϫ mice fed both a regular chow diet and a 24-wk Western diet. With a regular chow diet, iNOS did not contribute to any differences in either BH 4 (Fig.  3A , left) or BH 2 (Fig. 3B, left) in any of the tissues examined. Figure 3C , left, expresses these measurements as a BH 2 -to-BH 4 ratio and further highlights the fact that iNOS does not play a role in BH 4 and BH 2 levels when animals are fed a regular chow diet. However, as shown previously in Fig. 1, B and C, the administration of an atherogenic diet was associated with a marked oxidation of tissue BH 4 , as evidenced by the accumulation of 34 -50% of total biopterin as BH 2 in each of the study tissues (Fig. 3, A and B, right) . Furthermore, with the expression of these data as a BH 2 -to-BH 4 ratio, it is evident that the atherogenic diet induced BH 2 levels in all tissues of animals bearing the iNOS gene, apart from the liver (Fig. 3C, right) compared with a regular chow diet (Fig. 3C, left) . This atherogenic diet-induced accumulation of BH 2 was significantly and near-completely prevented by iNOS gene deletion in heart (0.12 Ϯ 0.10 pmol/mg protein in iNOS Ϫ/Ϫ vs. 1.3 Ϯ 0.3 pmol/mg protein in iNOS ϩ/ϩ mice), lung (0.38 Ϯ 0.11 pmol/mg protein in iNOS Ϫ/Ϫ vs. 5.4 Ϯ 1.7 pmol/mg protein in iNOS ϩ/ϩ mice), and kidney (1.2 Ϯ 0.3 pmol/mg protein in iNOS Ϫ/Ϫ vs. 5.5 Ϯ 1.5 pmol/mg protein in iNOS ϩ/ϩ mice) (Fig. 3B, right) . This protection against BH 4 oxidation afforded by iNOS gene deletion was concomitant with a diminished total biopterin content in the lung, kidney, and brain (73%, 50%, and 28% reduction, respectively, compared with that of iNOS ϩ/ϩ mice). Modest nonsignificant protection was afforded by iNOS gene deletion against atherogenic diet-induced BH 2 accumulation in brain (1.0 Ϯ 0.3 pmol/mg protein in iNOS Ϫ/Ϫ vs. 2.0 Ϯ 0.5 pmol/mg protein in iNOS ϩ/ϩ mice), and protection was not evident in liver (22.0 Ϯ 4.9 pmol/mg protein in iNOS Ϫ/Ϫ vs. 15.2 Ϯ 4.4 pmol/mg protein in iNOS ϩ/ϩ mice) (Fig. 3B, right) . Whereas iNOS expression affected BH 4 levels in the heart (2.6 Ϯ 0.2 pmol/mg protein in iNOS Ϫ/Ϫ vs. 1.4 Ϯ 0.3 pmol/mg protein in iNOS ϩ/ϩ ) and lung (2.6 Ϯ 0.5 pmol/mg protein in iNOS Ϫ/Ϫ vs. 5.3 Ϯ 2.1 pmol/mg protein in iNOS ϩ/ϩ ), it had no effect on absolute levels of BH 4 in liver, kidney, and brain (Fig. 3A, right) .
Comparative expression of eNOS and nNOS in tissues of Western diet-fed ApoE
Ϫ/Ϫ and ApoE Figure 4 compares eNOS and nNOS protein expression in the heart, lung, liver, kidney, and brain of ApoE Ϫ/Ϫ and , and dihydrobiopterin (BH2; C) in tissues from apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice before and after feeding a Western diet for 24 wk. Hearts, lungs, livers, kidneys, and brains were removed from ApoE Ϫ/Ϫ mice at 3 wk of age (n ϭ 4) and after feeding a Western diet for an additional 24 wk (n ϭ 9). Organs were analyzed for protein 3-NT and biopterin levels, as described in MATERIALS AND METHODS. *P Ͻ 0.05, significantly different values for protein 3-NT, BH4, and BH2 in tissues from mice fed a Western diet for 24 wk compared with tissues from 3-wk-old mice.
ApoE
Ϫ/Ϫ -iNOS Ϫ/Ϫ mice fed a Western diet for 24 wk. Notably, eNOS protein was detected in all tissues examined from both ApoE Ϫ/Ϫ and ApoE
-iNOS Ϫ/Ϫ mice. In contrast, whereas nNOS protein was robustly detected in the brains and hearts of ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice, very little or no nNOS was observed in the lung, liver, or kidney. These findings provide no evidence of compensation for iNOS gene deletion by the other NOS isoforms, eNOS and nNOS. 
. Protein 3-NT in tissues from ApoE
Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice fed either regular chow or Western diets for 24 wk. Hearts, lungs, livers, kidneys, and brains were removed from ApoE Ϫ/Ϫ (n ϭ 5, regular chow diet; and n ϭ 9, Western diet) or ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ (n ϭ 5, regular chow diet; and n ϭ 20, Western diet) mice. Organs were analyzed for protein 3-NT levels as described in MATERIALS AND METHODS. *P Ͻ 0.05, significantly different values from mice with the ability to express iNOS compared with iNOS-null mice. #P Ͻ 0.05, significantly different values between mice on a Western diet compared with the same genotype on a regular chow diet.
Fig. 3. BH4 (A) and BH2 (B) levels in tissues from ApoE
Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice fed either regular chow or Western diets for 24 wk. Hearts, lungs, livers, kidneys, and brains were removed from ApoE Ϫ/Ϫ (n ϭ 5, regular chow diet; and n ϭ 9, Western diet) or ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ (n ϭ 5, regular chow diet; and n ϭ 20, Western diet) mice. Organs were analyzed for BH4 and BH2 levels, as described in MATERIALS AND METHODS. *P Ͻ 0.05, significantly different values for BH4 and BH2 in tissues from mice with the ability to express iNOS compared with iNOS-null mice. #P Ͻ 0.05, significantly different values between mice on a Western diet compared with the same genotype on a regular chow diet. C: results in A and B expressed as a ratio of BH2 to BH4.
from ApoE Ϫ/Ϫ mice compared with ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice (Fig. 5A) . Notably, lower 3-NT levels were found in mice fed a regular chow diet. With respect to BH 4 and BH 2 , very low levels were measured in each case which were unaffected by either iNOS gene deletion or diet (Fig. 5B ). Since these levels are close to the detection limit of our instrumentation, it is notable that small differences would be difficult to discern. An examination of NOS protein levels in lesions removed from aortae of Western diet-fed mice revealed the presence of iNOS protein in Western diet-fed ApoE Ϫ/Ϫ mice (Fig. 5C) , which was missing, as expected, in lesions from ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice. Furthermore, iNOS was not detected in the surrounding aortic tissue of these Western diet-fed mice (data not shown). It is noteworthy that aortae from regular chow-fed mice do not contain the volume of lesions observed in Western diet-fed mice, which prevented us from conducting a similar study in these animals. Figure 5C also shows that eNOS and low levels of nNOS were present at indistinguishable levels in ApoE
and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ lesions and thus do not appear to compensate for the absence of iNOS.
iNOS gene deletion does not influence serum lipid profiles and glucose in either regular chow or Western diet-fed ApoE
Ϫ/Ϫ and ApoE
-iNOS Ϫ/Ϫ mice. As shown in Fig. 6 , serum cholesterol, glucose, triglycerides, and LDL profiles were indistinguishable in mouse cohorts on ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ genetic backgrounds within the two diet groups. These results indicate that the protection afforded by iNOS gene deletion against protein nitration and BH 4 oxidation was not due to a correction of lipid profile defects. A further conclusion that can be drawn from Fig. 6 is that the administration of a Western diet resulted in significant increases in Thus the mice on the Western diet in our study exhibited serum cholesterol, triglyceride, and LDL levels that were, respectively, 10-, 3-, and 25-fold over values measured for control wild-type mice on a regular diet. In contrast, glucose levels in nonfasted control wild-type mice (187 Ϯ 10 mg/dl) were comparable with those reported for ApoE Ϫ/Ϫ (regular diet 232 Ϯ 14 mg/dl; Western diet 213 Ϯ 22 mg/dl) and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice (regular diet 206 Ϯ 13 mg/dl; Western diet 175 Ϯ 13 mg/dl) regardless of diet. Fig. 5 . Protein 3-NT (A), BH4 and BH2 levels (B), and nitric oxide synthase protein expression (C) in aortae from ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice. 3-NT, BH4, and BH2 levels were measured in aortae from ApoE Ϫ/Ϫ mice with and without iNOS fed a regular chow or Western diet (n ϭ 10 for each category). For each separate measurement, it was necessary to pool aortae from 2 to 3 mice. *P Ͻ 0.05, significantly different values. C: lesions were dissected from aortae removed from ApoE Ϫ/Ϫ mice with and without iNOS that had been fed a Western diet for 24 wk and probed for iNOS, eNOS, and nNOS. Each lane represents a measurement using lesions from a separate mouse. 
DISCUSSION
Our findings establish an essential and specific role for iNOS-derived reactive nitrogen species in the profound accumulation of protein 3-NT and BH 2 in peripheral organs of a murine genetic model of diet-induced atherosclerosis.
Atherosclerosis is a chronic vasoinflammatory condition (42), characterized by endothelial dysfunction (16) , defined by insufficient NO bioactivity (6) . Paradoxically, immunohistochemistry and Western blot analysis experiments have shown an increase in NOS enzyme expression in atherosclerotic lesions from animal disease models (4) and human patients (7) . NO insufficiency, despite abundant NOS in atherosclerotic vessels, has been reconciled by two additional disease features: 1) accelerated consumption of NO bioactivity, via the near diffusion-limited reaction of NO with O 2
•Ϫ that emanates from multiple cell sources [including NADPH oxidase, xanthine oxidase, inefficiencies of mitochondrial electron transport, and uncoupled NOSs (31)] and 2) diminished NO biosynthetic activity of NOSs, owing to ONOO Ϫ -mediated oxidation of the essential NOS cofactor, BH 4 (29) . Since BH 4 oxidation results in NOS uncoupling and a consequent increase in the rate of NOS-derived O 2
•Ϫ production (50), atherosclerotic blood vessels may be prone to a feed-forward acceleration in the rate of ONOO Ϫ generation, at the expense of NO bioactivity. In addition to failing endothelium-mediated vasodilatation, the resulting loss of NO bioactivity can promote vascular inflammation (17) and thereby accelerate lesion progression. BH 4 oxidation by reactive nitrogen species provides a unifying mechanistic link between oxidative stress and endothelial dysfunction in chronic vascular conditions, including atherogenesis.
This study employed a genetic approach to elucidate, organ by organ, the specific role of iNOS-derived reactive species in hallmark oxidative reactions of atherogenesis: protein 3-NT accumulation and BH 4 oxidation. Notably, each of these oxidative reactions has been attributed to increased ONOO Ϫ production in atherosclerotic blood vessels, arising from an accelerated production of O 2
•Ϫ and reaction with NOS-derived NO. Since the kinetics of BH 4 oxidation by ONOO Ϫ far exceed the rate of oxidation by O 2
•Ϫ (29), the formation of ONOO Ϫ is likely to be the key determinant of the BH 4 oxidation status in the endothelium of atherosclerotic blood vessels. Multiple sources of NO can contribute to ONOO Ϫ overproduction in atherogenic lesions. However, a growing body of literature has implicated uncoupled eNOS as a predominant contributor to ONOO Ϫ formation in advanced lesions (41) . The present findings reveal an essential, permissive role of iNOS in atherogenic-associated reactions of ONOO Ϫ in diverse tissues.
We observed a marked accumulation of protein 3-NT and oxidized BH 4 (i.e., BH 2 ) in organs of ApoE Ϫ/Ϫ mice, after 24 wk of feeding a Western diet. The extent of 3-NT accumulation varied dramatically in the various organs studied. Whereas heart, lung, liver, and kidney exhibited the greatest 3-NT accumulation (ranging from a 280-fold to 6-fold increase), brain proteins showed only a small and nonsignificant increase in 3-NT (0.3-fold). This differential tissue distribution of protein 3-NT accumulation is likely to reflect the extent of ONOO Ϫ generated within each organ, which, in turn, can be related to the extent of antioxidant reserves and tissue propensity for atherogenic diet-evoked tissue inflammation. It is important to consider that 3-NT formation may also arise from nitrite metabolism by a peroxidase enzyme in the presence of hydrogen peroxide (36, 39) . The failure of a Western diet to increase protein 3-NT in brain is a predictable consequence of the protection afforded by the blood-brain barrier against central nervous system entry of proinflammatory cytokines. Although brain 3-NT was not increased by a 24-wk atherogenic diet, the brain is an apparent site of marked overproduction of NO and NO-derived species even in healthy young mice (3-wk-old ApoE
Ϫ/Ϫ
). This is indicated by a fourfold or greater increase in brain protein 3-NT versus 3-NT in every other organ studied herein.
In contrast to the organ-to-organ variability observed for protein 3-NT accumulation, we observed a uniform atherogenic diet-induced oxidation of BH 4 . Indeed, oxidation of BH 4 Fig. 6 . iNOS gene deletion does not influence serum lipid profiles and glucose levels in either regular chow or Western diet-fed ApoE Ϫ/Ϫ mice. Serum levels of cholesterol, glucose, triglyceride, and LDL were measured in wild-type mice fed a regular chow diet for 28 wk (left) and in ApoE Ϫ/Ϫ and ApoE Ϫ/Ϫ -iNOS Ϫ/Ϫ mice fed a regular chow (middle) or Western diet (right) for 24 wk, as described in MATERIALS AND METHODS. Numbers represent averages from using serum from 10 or more mice. *P Ͻ Ͻ 0.05 compared with wild-type mice. #P Ͻ Ͻ 0.05 compared with counterparts on a regular chow diet.
to BH 2 ranged from 30% to 50% of total biopterin in all organs (apart from aortae) analyzed from Western diet-fed ApoE Ϫ/Ϫ mice. Before commencement of the atherogenic diet, it is notable that BH 2 was undetectable in any tissue but liver, where BH 2 levels were only Ϸ12% of total biopterin. Furthermore, BH 2 levels were low in tissues from ApoE Ϫ/Ϫ mice administered a regular chow diet. Thus accumulation of tissue BH 2 may provide a telling biomarker for advanced atherosclerotic disease. It has previously been reported that BH 2 levels remain unchanged in aortae of ApoE Ϫ/Ϫ mice on a Western diet compared with wild-type mice (10) . In our study, we also observed that BH 2 did not accumulate in aortae from Western diet-fed mice compared with regular chow-fed mice. However, our results concerning BH 4 levels are at variance with the previous study, in which an accumulation of BH 4 was noted in mice on an atherogenic diet (10). Our results indicate that BH 4 levels are similar in mice fed either a regular chow or Western diet. A difference is that hypercholesterolemia was more severe in our atherosclerotic model (cholesterol ϭ 22 Ϯ 2 mmol/l) compared with that in the earlier report (5.6 Ϯ 0.3 mmol/l) (10). We measured circulating levels of cholesterol that were ϳ10 times higher than in wild-type mice. Indeed, in atherosclerotic rabbits with cholesterol levels 28 times higher than in control animals, markedly diminished BH 4 levels were found (50a). Thus BH 4 availability may depend on the severity of hypercholesterolemia.
Despite the substantial Western diet-elicited oxidation of BH 4 in organs, it is notable that absolute BH 4 levels were relatively undiminished; BH 4 preservation was due to an increase in the total biopterin content in heart, liver, lung, or brain. When compared with mice on a regular chow diet, BH 4 levels were slightly diminished. An increase in total biopterin is explained by a Western diet-induced and tissue-selective upregulation of the rate-limiting enzyme in the de novo BH 4 biosynthesis, GTP cyclohydrolase 1 (GTPCH1). GTPCH1 is a well-established protein biomarker of tissue immunoactivation and inflammation (52) and was recently shown to be upregulated in aortae of ApoE Ϫ/Ϫ mice, but only after a minimum of 20 wk on a Western diet (10) . We now broadly extend this prior finding of atherogenic diet-induced BH 4 synthesis upregulation, from lesion-laden conductance vessels to diverse tissues with predominantly microvascular lesions [e.g., kidney (51) ].
Prior studies using ApoE Ϫ/Ϫ mice have established that each of the three NOS gene products are expressed in atherosclerotic blood vessels (54) and can play a disease-modulatory role (13, 23, 26, 38) . Inasmuch as atherogenesis is a vasoinflammatory condition, which is associated with proinflammatory cytokine release (42) , it is reasonable that cytokine-induced iNOS could contribute prominently to the generation of reactive nitrogen species that mediate protein nitration, BH 4 oxidation, and endothelial dysfunction. Studies reported herein using iNOSnull mice clearly establish the organ-specific role of iNOSderived NO for BH 4 oxidation and protein nitration in Western diet-fed ApoE Ϫ/Ϫ mice. Among the organs studied (heart, lung, liver, kidney, and brain), iNOS gene deletion was associated with an essentially complete protection against BH 4 oxidation in all tissues but liver, and a Ͼ75% attenuation in protein 3-NT accumulation was found in all tissues but brain and lung. The differential contribution of iNOS-derived NO for protein nitration versus BH 4 oxidation in any given tissue was unanticipated. This may be a consequence of multiple NOS isoforms and antioxidant defense mechanisms that are present in each tissue but nonuniformly distributed. Failure of iNOS gene deletion to suppress significantly protein nitration in kidney and brain can be explained by a major role of other NOS isoforms, likely eNOS and nNOS, respectively. Significantly, we found that eNOS and nNOS did not compensate for the absence of iNOS in any of the tissues examined.
In summary, our results demonstrate that iNOS-derived species are required for robust atherosclerosis-associated ONOO Ϫ production in peripheral organs. The observed organselective contribution of iNOS to ONOO Ϫ formation, deduced from protein 3-NT incorporation and BH 4 oxidation, additionally suggests a variable contribution of constitutive NOS isoforms to the formation of proatherogenic reactive nitrogen intermediates in some organs. We hypothesize that although proinflammatory cytokine-induced iNOS provides the key source of NO for an initial acceleration of vascular ONOO Ϫ production during early stage atherogenesis, the consequent oxidation of BH 4 would allow cofactor-depleted ("uncoupled") eNOS to serve as a sustaining source of ONOO Ϫ precursors in later-stage disease.
